Paul Korner - 19 Jan 2022 Form 4 Insider Report for AGILE THERAPEUTICS INC

Role
Sr. VP and CMO
Signature
/s/ Geoffrey P. Gilmore, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
19 Jan 2022
Net transactions value
$0
Form type
4
Filing time
20 Jan 2022, 20:31:29 UTC
Next filing
14 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGRX Employee Stock Option (Right to Buy) Award $0 +225,000 $0.000000 225,000 19 Jan 2022 Common Stock 225,000 $0.3420 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on January 19, 2022. 25% of the shares subject to the stock option vest on January 19, 2023, and the remaining shares vest in 36 substantially equal monthly installments over the following three years such that the option will be fully vested on January 19, 2026.